CP and cancer: When CP enters into CAD, it will combine with aspartate to produce carbamyl aspartate by the action of ATCase, and then is further converted to orotic acid causing its elevation, eventfully resulting in nucleotide imbalance [145], a possible mechanism contributing to the cancer-promoting action of orotic acid [146].